Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT.

Hepatol Int · 2022 · PMC8942063 · PMID 35322373

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Conclusion G-CSF therapy is safe in DC, mobilizes CD 34+ cells, and is associated with a reduction in 1-year mortality that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.